MDT

100.71

-0.28%↓

A

135.73

+0.63%↑

VEEV

223.72

+0.88%↑

HQY

85.01

+1.03%↑

NEOG

10

+1.94%↑

MDT

100.71

-0.28%↓

A

135.73

+0.63%↑

VEEV

223.72

+0.88%↑

HQY

85.01

+1.03%↑

NEOG

10

+1.94%↑

MDT

100.71

-0.28%↓

A

135.73

+0.63%↑

VEEV

223.72

+0.88%↑

HQY

85.01

+1.03%↑

NEOG

10

+1.94%↑

MDT

100.71

-0.28%↓

A

135.73

+0.63%↑

VEEV

223.72

+0.88%↑

HQY

85.01

+1.03%↑

NEOG

10

+1.94%↑

MDT

100.71

-0.28%↓

A

135.73

+0.63%↑

VEEV

223.72

+0.88%↑

HQY

85.01

+1.03%↑

NEOG

10

+1.94%↑

Search

Stevanato Group SpA

Abrir

SetorSaúde

17.6 -2.28

Visão Geral

Variação de preço das ações

24h

Atual

Mín

17.02

Máximo

17.99

Indicadores-chave

By Trading Economics

Rendimento

10M

49M

Vendas

23M

303M

P/E

Médio do Setor

33.475

89.037

EPS

0.162

Rendimento de Dividendos

0.26

Margem de lucro

16.205

Funcionários

5,521

EBITDA

10M

73M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+56.34% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

0.26%

2.18%

Próximos Ganhos

5 de mar. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-1.3B

5.4B

Abertura anterior

19.88

Fecho anterior

17.6

Sentimento de Notícias

By Acuity

50%

50%

141 / 352 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Weak Bullish Evidence

Stevanato Group SpA Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

26 de jan. de 2026, 23:49 UTC

Ações em Alta

Stocks to Watch: Agilysys, Nucor, Humana, UnitedHealth

26 de jan. de 2026, 23:09 UTC

Grandes Movimentos do Mercado

Health Insurers' Shares Fall After Government Proposes Flat Medicare Advantage Rate

26 de jan. de 2026, 23:52 UTC

Conversa de Mercado

Gold's Path of Least Resistance Still Looks Higher, Technical Analysis Shows -- Market Talk

26 de jan. de 2026, 23:46 UTC

Conversa de Mercado

Nikkei May Decline as Yen's Rebound Raises Caution Over Earnings -- Market Talk

26 de jan. de 2026, 23:37 UTC

Conversa de Mercado

Gold Rises Amid Concerns Over Tariffs -- Market Talk

26 de jan. de 2026, 22:41 UTC

Conversa de Mercado

Australian 4Q CPI To Provide Smoking Gun For Hike -- Market Talk

26 de jan. de 2026, 22:26 UTC

Ganhos

Karoon Expects Capex of US$110 Million-US$135 Million in 2026

26 de jan. de 2026, 22:26 UTC

Ganhos

Karoon Expects Operating Costs to Fall Once Transition of Bauna FPSO Operatorship Completes

26 de jan. de 2026, 22:25 UTC

Ganhos

Karoon Energy Expects Unit Production Cost of US$12-US$15/BOE in 2026

26 de jan. de 2026, 22:25 UTC

Ganhos

Karoon Energy Expects Output to Rise in 2H Following Bauna Investment Program

26 de jan. de 2026, 22:25 UTC

Ganhos

Karoon Energy Expects Output of 8.1 Million-9.2 Million BOE in 2026

26 de jan. de 2026, 22:24 UTC

Ganhos

Karoon Energy 4Q Sales Revenue US$156.1 Million

26 de jan. de 2026, 22:23 UTC

Ganhos

Karoon Energy 4Q Sales Volumes 2.65 Million BOE, Up 5% on Quarter

26 de jan. de 2026, 22:23 UTC

Ganhos

Karoon Energy: Bauna FPSO Efficiency Increased to 98.8%

26 de jan. de 2026, 22:23 UTC

Ganhos

Karoon Energy FY Oil, Natural Gas Production 10.3 Million BOE

26 de jan. de 2026, 22:22 UTC

Ganhos

Karoon Energy 4Q Oil, Natural Gas Production 2.37 Million BOE

26 de jan. de 2026, 22:05 UTC

Aquisições, Fusões, Aquisições de Empresas

Fortescue: Alta Copper Shareholders Approve Takeover

26 de jan. de 2026, 22:02 UTC

Aquisições, Fusões, Aquisições de Empresas

Senate Antitrust Panel Chair Raises Concerns Over Netflix-Warner Deal -- WSJ

26 de jan. de 2026, 21:50 UTC

Conversa de Mercado
Ganhos

Financial Services Roundup: Market Talk

26 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Auto & Transport Roundup: Market Talk

26 de jan. de 2026, 21:34 UTC

Ganhos

Nucor: Steel Products Segment Expected Improved Earnings in 1Q Due to Increased Volumes on Stable Pricing >NUE

26 de jan. de 2026, 21:34 UTC

Ganhos

Nucor: Steel Mills Segment Expected Increase Is Due to Higher Volumes and Higher Realized Prices Across All Major Pdt Categories >NUE

26 de jan. de 2026, 21:34 UTC

Ganhos

Nucor: Raw Materials Segment Is Expected to Have Increased Earnings in 1Q >NUE

26 de jan. de 2026, 21:34 UTC

Ganhos

Nucor: 1Q Earnings Expected to Increase Across All Three Operating Segments, With the Largest Increase in Steel Mills Segment >NUE

26 de jan. de 2026, 21:30 UTC

Aquisições, Fusões, Aquisições de Empresas

Eaton Stock Rises on Spin-Off Plan. Why It's Going All-In on Planes and AI Data Centers. -- Barrons.com

26 de jan. de 2026, 21:30 UTC

Ganhos

Nucor 4Q Sales $7.69B >NUE

26 de jan. de 2026, 21:30 UTC

Ganhos

Nucor 4Q Net $378M >NUE

26 de jan. de 2026, 21:30 UTC

Ganhos

Nucor 4Q Steel Mills Total Shipments 5.91M Tons >NUE

26 de jan. de 2026, 21:30 UTC

Ganhos

Nucor 4Q Total Tons Shipped to Outside Customers Down 9% >NUE

26 de jan. de 2026, 21:30 UTC

Ganhos

Nucor 4Q EPS $1.64 >NUE

Comparação entre Pares

Variação de preço

Stevanato Group SpA Previsão

Preço-alvo

By TipRanks

56.34% parte superior

Previsão para 12 meses

Média 27 USD  56.34%

Máximo 30 USD

Mínimo 24 USD

Com base em 3 analistas de Wall Street que oferecem metas de preço de 12 meses para Stevanato Group SpA - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

3 ratings

2

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

21.56 / 22.61Suporte e Resistência

Curto Prazo

Weak Bullish Evidence

Médio Prazo

Weak Bearish Evidence

Longo Prazo

Bullish Evidence

Sentimento

By Acuity

141 / 352 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Stevanato Group SpA

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
help-icon Live chat